ISOPROTERENOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Isoproterenol Hydrochloride patents expire, and when can generic versions of Isoproterenol Hydrochloride launch?
Isoproterenol Hydrochloride is a drug marketed by 3M, Alpharma Us Pharms, Abraxis Pharm, Am Regent, Amneal, Amphastar Pharms Inc, Amring Pharms, Avet Lifesciences, Baxter Hlthcare, Cipla, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Intl Medication, Micro Labs, Nexus, Norvium Bioscience, Penn Life, Somerset Theraps Llc, Zydus Pharms, Armour Pharm, DEY, and Parke Davis. and is included in twenty-eight NDAs.
The generic ingredient in ISOPROTERENOL HYDROCHLORIDE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isoproterenol Hydrochloride
A generic version of ISOPROTERENOL HYDROCHLORIDE was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOPROTERENOL HYDROCHLORIDE?
- What are the global sales for ISOPROTERENOL HYDROCHLORIDE?
- What is Average Wholesale Price for ISOPROTERENOL HYDROCHLORIDE?
Summary for ISOPROTERENOL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 28 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Clinical Trials: | 25 |
| Patent Applications: | 954 |
| What excipients (inactive ingredients) are in ISOPROTERENOL HYDROCHLORIDE? | ISOPROTERENOL HYDROCHLORIDE excipients list |
| DailyMed Link: | ISOPROTERENOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ISOPROTERENOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Alberta | Phase 1 |
| Ningbo No. 1 Hospital | Phase 4 |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
Pharmacology for ISOPROTERENOL HYDROCHLORIDE
| Drug Class | beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta-Agonists |
US Patents and Regulatory Information for ISOPROTERENOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | SOLUTION;INHALATION | 085540-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| 3m | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | AEROSOL, METERED;INHALATION | 010375-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Micro Labs | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 210845-001 | Feb 16, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Armour Pharm | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | SOLUTION;INHALATION | 087935-001 | Nov 18, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
